Shouchao Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shouchao Xu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Haitong Wan
Academy of Chinese Medical Sciences, Henan University of Chinese Medicine
1 shared publication Jianzhen Chen
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
1 shared publicationKunjun Mao
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
1 shared publicationLei Jin
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
1 shared publication- Ping Huang
Clinical Pharmacy Department, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University , 453 Tiyu Road, Xihu District, Hangzhou 31007 , Zhejiang
1 shared publication Ting Zhang
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
1 shared publication
Latest Publications
- 30 August 2022
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 13 (18) , 9658-9673
Optimization of smashing tissue and ultrasonic extraction of tanshinones and their neuroprotective effect on cerebral ischemia/reperfusion injury by inhibiting parthanatos
A green smashing tissue and ultrasonic (STU) extraction method, which combines smashing tissue and ultrasonic-assisted extraction, was developed for the first time. The extraction of tanshinones from Salvia miltiorrhiza Bunge (SM) was taken as an example to discuss the practicability of this method. Taking the total yield of eight tanshinones as an evaluation index, response surface methodology (RSM) and artificial neural network (ANN) models were used to optimize the extraction parameters, and these two models were also compared by investigating the extract yield of tanshinones and the antioxidant activity of the obtained SM extract. The optimal STU conditions by ANN were as follows: an ethanol concentration of 73%, a liquid/solid ratio of 30 mL g−1, a smashing tissue time of 97 s and an ultrasonic time of 40 min. Under these optimal conditions, the yield of the eight components was 0.30% ± 0.12, which was greater than 0.28% ± 0.03 optimized by RSM. The IC50 values of 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) of the obtained extract were 55.25 ± 3.72 μg mL−1 and 67.33 ± 2.62 μg mL−1, respectively, which were better than those of 75.49 ± 4.33 μg mL−1 and 112.10 ± 5.98 μg mL−1, respectively, optimized by RSM. Furthermore, the SM extract was found to exert neuroprotective effects by inhibiting parthanatos in middle cerebral artery occlusion/reperfusion (MCAO/R)-induced rats. The results supported the use of the SM extract, which was obtained by STU, as a potential product in the cosmetics, medicine, and food industries.
- 30 August 2022
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 13 (18) , 9658-9673
Optimization of smashing tissue and ultrasonic extraction of tanshinones and their neuroprotective effect on cerebral ischemia/reperfusion injury by inhibiting parthanatos
A green smashing tissue and ultrasonic (STU) extraction method, which combines smashing tissue and ultrasonic-assisted extraction, was developed for the first time. The extraction of tanshinones from Salvia miltiorrhiza Bunge (SM) was taken as an example to discuss the practicability of this method. Taking the total yield of eight tanshinones as an evaluation index, response surface methodology (RSM) and artificial neural network (ANN) models were used to optimize the extraction parameters, and these two models were also compared by investigating the extract yield of tanshinones and the antioxidant activity of the obtained SM extract. The optimal STU conditions by ANN were as follows: an ethanol concentration of 73%, a liquid/solid ratio of 30 mL g−1, a smashing tissue time of 97 s and an ultrasonic time of 40 min. Under these optimal conditions, the yield of the eight components was 0.30% ± 0.12, which was greater than 0.28% ± 0.03 optimized by RSM. The IC50 values of 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) of the obtained extract were 55.25 ± 3.72 μg mL−1 and 67.33 ± 2.62 μg mL−1, respectively, which were better than those of 75.49 ± 4.33 μg mL−1 and 112.10 ± 5.98 μg mL−1, respectively, optimized by RSM. Furthermore, the SM extract was found to exert neuroprotective effects by inhibiting parthanatos in middle cerebral artery occlusion/reperfusion (MCAO/R)-induced rats. The results supported the use of the SM extract, which was obtained by STU, as a potential product in the cosmetics, medicine, and food industries.